Avidity Partners Takes 6.36M Share Stake in Caribou Biosciences

TL;DR

**Avidity Partners just bought over 6.3 million shares of Caribou Biosciences, a big vote of confidence!**

AI Summary

Avidity Partners Management LP, a Delaware-based investment firm, reported acquiring shared voting and dispositive power over 6,360,212 shares of Caribou Biosciences, Inc. common stock as of December 29, 2023. This represents a significant stake in the gene-editing company, indicating Avidity Partners' bullish outlook on Caribou's future. For investors, this signals a notable institutional endorsement, potentially boosting confidence and attracting further investment into Caribou Biosciences.

Why It Matters

This filing reveals a major institutional investor, Avidity Partners, has taken a substantial position in Caribou Biosciences, signaling their confidence in the company's prospects.

Risk Assessment

Risk Level: low — This filing indicates a large institutional investment, generally seen as a positive signal and not inherently risky.

Analyst Insight

A smart investor would view this as a positive signal, potentially researching Caribou Biosciences further to understand the underlying reasons for Avidity Partners' significant investment.

Key Numbers

• 6,360,212 — Shares Beneficially Owned (Represents the total number of Caribou Biosciences shares Avidity Partners Management LP has shared voting and dispositive power over.)
• 142038108 — CUSIP Number (Unique identifier for Caribou Biosciences, Inc. common stock.)
• December 29, 2023 — Event Date (The specific date that triggered the requirement for Avidity Partners Management LP to file this Schedule 13G.)

Key Players & Entities

• Avidity Partners Management LP (company) — the reporting person acquiring shares
• Caribou Biosciences, Inc. (company) — the subject company whose shares were acquired
• 6,360,212 (dollar_amount) — number of shares beneficially owned
• December 29, 2023 (person) — date of event requiring the filing
• Delaware (company) — place of organization for Avidity Partners Management LP

Forward-Looking Statements

• Caribou Biosciences' stock price may see increased investor confidence and potential upward movement due to this significant institutional investment. (Caribou Biosciences, Inc.) — medium confidence, target: Q1 2024
• Avidity Partners Management LP may increase its stake in Caribou Biosciences if the company's clinical pipeline progresses positively. (Avidity Partners Management LP) — low confidence, target: Q3 2024

FAQ

Key Financial Figures

• $0.0001 — me of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• d10927867_13-g.htm (SC 13G) — 191KB
• 0000919574-24-000156.txt ( ) — 193KB

From the Filing

SC 13G 1 d10927867_13-g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* Caribou Biosciences, Inc. (Name of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securities) 142038108 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 142038108 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Avidity Partners Management LP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 6,360,212 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 6,360,212 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,360,212 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.2% 1 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IA, PN 1 The percentage of ownership based on 88,431,136 shares of Common stock of the Issuer outstanding as of November 2, 2023, as reported on the Issuer’s Form 10-Q filed on November 7, 2023. CUSIP No. 142038108 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Avidity Partners Management (GP) LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 6,360,212 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 6,360,212 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,360,212 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.2% 2 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO 2 The percentage of ownership based on 88,431,136 shares of Common stock of the Issuer outstanding as of November 2, 2023, as reported on the Issuer’s Form 10-Q filed on November 7, 2023. CUSIP No. 142038108 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Avidity Capital Partners Fund (GP) LP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 6,360,212 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 6,360,212 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,360,212 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.2% 3 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO, PN 3 The percentage of ownership based on 88,431,136 shares of Common stock of the Issuer outstanding as of November 2, 2023, as reported on the Issuer’s Form 10-Q filed on November 7, 2023. CUSIP No. 142038108 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Avidity Capital Partners (GP) LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 6,360,212 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 6,360,212 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,360,212 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCEN

View Full Filing

View this SC 13G filing on SEC EDGAR